Malignant mixed Mullerian tumors of the uterus: histopathological evaluation of cell cycle and apoptotic regulatory proteins
Open Access
- 19 July 2010
- journal article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 8 (1) , 60
Abstract
The aim of our study was to evaluate survival outcomes in malignant mixed Mullerian tumors (MMMT) of the uterus with respect to the role of cell cycle and apoptotic regulatory proteins in the carcinomatous and sarcomatous components. 23 cases of uterine MMMT identified from the Saskatchewan Cancer Agency (1970-1999) were evaluated. Immunohistochemical expression of Bad, Mcl-1, bcl-x, bak, mdm2, bax, p16, p21, p53, p27, EMA, Bcl-2, Ki67 and PCNA was correlated with clinico-pathological data including survival outcomes. Histopathological examination confirmed malignant epithelial component with homologous (12 cases) and heterologous (11 cases) sarcomatous elements. P53 was strongly expressed (70-95%) in 15 cases and negative in 5 cases. The average survival in the p53+ve cases was 3.56 years as opposed to 8.94 years in p53-ve cases. Overexpression of p16 and Mcl-1 were observed in patients with longer survival outcomes (>2 years). P16 and p21 were overexpressed in the carcinomatous and sarcomatous elements respectively. Cyclin-D1 was focally expressed only in the carcinomatous elements. Our study supports that a) cell cycle and apoptotic regulatory protein dysregulation is an important pathway for tumorigenesis and b) p53 is an important immunoprognostic marker in MMMT of the uterus.Keywords
This publication has 76 references indexed in Scilit:
- Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tubeInternational Journal of Clinical Oncology, 2008
- Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinomaGynecologic Oncology, 2006
- Malignant mixed mullerian tumor of primary mesenteric originInternational Journal of Gynecological Cancer, 2005
- Malignant mixed mullerian tumour of the fallopian tube occurring in a patient with Peutz-Jegher's syndromeAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2004
- Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancersInternational Journal of Clinical Oncology, 2002
- ApoptosisCell, 2002
- Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Müllerian tumoursThe Journal of Pathology, 1997
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- MIXED MESODERMAL SARCOMA OF THE UTERUSAmerican Journal of Roentgenology, 1973